Our research focuses on the pathophysiology of mental disorders, their early detection, and their prevention and treatment.
We strive to improve the prediction of psychotic disorders in young high-risk patients, and investigate the neurofunctional mechanisms and efficacy of potential innovative treatments such as cannabinoids and psychedelics. We apply a variety of methods in pharmacological and clinical studies.
We are an interdisciplinary team consisting of scientists and health care personnel from the fields of psychiatry, psychology, physicians/medicine, neurosurgery, neurophysiology, mathematics, and biomedical engineering. We drive innovative, translational science forward by combining our diverse set of expertise.
Our research combines clinical excellence in early intervention with extensive expertise in conducting interdisciplinary research in several key areas revolving around psychotic disorders. These include their prediction, neurofunctional and cognitive mechanisms, and efficacy of potential innovative treatments. We run a variety of pharmacological, clinical, and intervention studies that will support the development of tools for individualized prediction and treatment.